Cover Image

Molecular clusters reveal opportunities for personalised small cell lung cancer immunotherapy

Saved in:

Bibliographic Details
Main Authors:	Longjin Zeng (Author), Lingchen Li (Author), Xingyun Liao (Author), Chenrui Yin (Author), Lincheng Zhang (Author), Jianguo Sun (Author)
Format:	Book
Published:	Wiley, 2022-09-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Current status of immunotherapy for non-small cell lung cancer
by: Tao Yang, et al.
Published: (2022)

The Treatment of Metastatic Non-small Cell Lung Cancer (NSCLC) in New Era of Personalised Medicine
by: Barbara Melosky
Published: (2015)

Update on the Treatment of Metastatic Non-small Cell Lung Cancer (NSCLC) in New Era of Personalised Medicine
by: Barbara Melosky
Published: (2018)

Advances in Targeted Therapy and Immunotherapy for Non-small Cell Lung Cancer Based on Accurate Molecular Typing
by: Jingsi Dong, et al.
Published: (2019)

Potential predictors of immunotherapy in small cell lung cancer
by: Valeria Skopelidou, et al.
Published: (2023)

PHARMACOECONOMIC ASPECTS OF NON-SMALL CELL LUNG CANCER IMMUNOTHERAPY
by: A. V. Rudakova, et al.
Published: (2017)

First line Immunotherapy for Non-Small Cell Lung Cancer
by: Nicola J. Nasser, et al.
Published: (2020)

Proteomic analysis reveals the molecular mechanism of Astragaloside in the treatment of non-small cell lung cancer by inducing apoptosis
by: Jiaqi Liu, et al.
Published: (2023)

Efficacy of immunotherapy in small cell lung cancer: A retrospective stude
by: Marina A. Lyadova, et al.
Published: (2024)

The key to immunotherapy: how to choose better therapeutic biomarkers for patients with non-small cell lung cancer
by: Yue Pan, et al.
Published: (2022)

Immunotherapy for a POLE Mutation Advanced Non-Small-Cell Lung Cancer Patient
by: Yang Fu, et al.
Published: (2022)

Immunotherapy in inoperable stage III non-small cell lung cancer: a review
by: Natasha A Jain, et al.
Published: (2019)

Rechallenge of immunotherapy beyond progression in patients with extensive-stage small-cell lung cancer
by: Lingling Li, et al.
Published: (2022)

Progressive Disease with Mixed Response After Immunotherapy in Non-Small Cell Lung Cancer
by: Lv J, et al.
Published: (2024)

The impact of the microbiota-gut-brain axis on endometriosis-associated symptoms: mechanisms and opportunities for personalised management strategies
by: Francesca Hearn-Yeates, et al.
Published: (2024)

Analysing spatio-temporal clustering of meningococcal meningitis outbreaks in Niger reveals opportunities for improved disease control.
by: Juliette Paireau, et al.
Published: (2012)

The role of nutrigenetics in diet personalisation
by: Karolina Rogulska, et al.
Published: (2021)

Immunotherapy in the treatment of non-small cell lung cancer (NSCLC) - analysis of epidemiology and cure - review
by: Kinga Ruszel, et al.
Published: (2020)

Evidence for the evolving role of neoadjuvant and perioperative immunotherapy in resectable non-small cell lung cancer
by: Thomas Hansen, et al.
Published: (2024)

Challenges and Opportunities for Effective Cancer Immunotherapies
Published: (2023)

Personalised cancer medicine Future crafting in the genomic era
by: Kerr, Anne
Published: (2021)

Personalised cancer medicine Future crafting in the genomic era
by: Kerr, Anne
Published: (2021)

Exploring the mechanism of 6-Methoxydihydrosanguinarine in the treatment of lung adenocarcinoma based on network pharmacology, molecular docking and experimental investigation
by: Xingyun Liu, et al.
Published: (2024)

Applied models and molecular characteristics of small cell lung cancer
by: Gabriella Mihalekné Fűr, et al.
Published: (2024)

The promises and perils of circulating tumor DNA for monitoring immunotherapy response in non-small cell lung cancer
by: Brandon Joseph Hebert, et al.
Published: (2024)

Conceptual and theoretical foundations of personalised learning
by: E. F. Zeer, et al.
Published: (2022)

User Satisfaction with Personalised Internet Applications
by: Bauernfeind, Ulrike
Published: (2018)

User Satisfaction with Personalised Internet Applications
by: Bauernfeind, Ulrike
Published: (2018)

Biomarkers in Psoriasis: The Future of Personalised Treatment
by: Bikash R. Kar, et al.
Published: (2024)

Smart Sensing Technologies for Personalised Coaching
Published: (2021)

Small-molecule agents for cancer immunotherapy
by: Fang Wang, et al.
Published: (2024)

The Personalised Acne Care Pathway-Recommendations to guide longitudinal management from the Personalising Acne: Consensus of ExpertsCapsule Summary
by: Jerry Tan, MD, et al.
Published: (2021)

Systematic Transcriptome Analysis Reveals the Inhibitory Function of Cinnamaldehyde in Non-Small Cell Lung Cancer
by: Ru Chen, et al.
Published: (2021)

Molecular characterization based on tumor microenvironment-related signatures for guiding immunotherapy and therapeutic resistance in lung adenocarcinoma
by: Yamin Jie, et al.
Published: (2023)

A network meta-analysis of immunotherapy-based treatments for advanced nonsquamous non-small cell lung cancer
by: Himani Aggarwal, et al.
Published: (2023)

Cost-effectiveness of the combination of immunotherapy and chemotherapy for extensive-stage small-cell lung cancer: a systematic review
by: Tao Wang, et al.
Published: (2023)

Metastatic squamous cell non-small-cell lung cancer (NSCLC): disrupting the drug treatment paradigm with immunotherapies
by: Sarah L Scarpace
Published: (2015)

Tetrandrine potentiates immunotherapy efficacy in non-small cell lung cancer: Modern wisdom of traditional Chinese medicine
by: Yuning Wang, et al.
Published: (2024)

MET Inhibitor is Expected to Overcome MET Amplification-Induced Immunotherapy Resistance in Non-Small Cell Lung Cancer
by: Ji Ruan
Published: (2021)

Tetrandrine activates STING/TBK1/IRF3 pathway to potentiate anti-PD-1 immunotherapy efficacy in non-small cell lung cancer
by: Yan Tan, et al.
Published: (2024)